Search filters

List of works by Fiona R Lamont

A global initiative to refine acute inhalation studies through the use of 'evident toxicity' as an endpoint: Towards adoption of the fixed concentration procedure.

scientific article

A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies.

scientific article published on 19 April 2013

Adverse Outcome Pathways can drive non-animal approaches for safety assessment

scientific article published on 5 May 2015

Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use.

scientific article

Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer

scientific article published on 19 May 2009

Identification and characterisation of the early differentiating cells in neural differentiation of human embryonic stem cells

scientific article

Opportunities to Apply the 3Rs in Safety Assessment Programs

scientific article published on December 2016

Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trials.

scientific article

Steps towards the international regulatory acceptance of non-animal methodology in safety assessment.

scientific article

Testing Chemical Safety: What Is Needed to Ensure the Widespread Application of Non-animal Approaches?

scientific article

The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspective.

scientific article published on 31 July 2017

The future trajectory of adverse outcome pathways: a commentary.

scientific article published on 16 March 2018